The new bill - Animal Welfare (Sentencing and Recognition of Sentience) - would increase the maximum prison sentence for animal cruelty tenfold, from six months to five years, in England and Wales.
The draft bill also sets out that the government "must have regard to the welfare needs of animals as sentient beings in formulating and implementing government policy".
Subject to consultation on the draft bill, the government says it will legislate to deliver both aims.
In fact, the draft bill goes further than Article 13 as it applies to all areas of government policy, rather than specified areas of policy. If passed, the law would apply to the whole of the UK.
Environment Secretary Michael Gove said: "Animals are sentient beings who feel pain and suffering, so we are writing that principle into law and ensuring that we protect their welfare. Our plans will also increase sentences for those who commit the most heinous acts of animal cruelty to five years in jail. We are a nation of animal lovers so we will make Brexit work not just for citizens but for the animals we love and cherish too."
BVA President John Fishwick said: "Vets have been clear in our calls that the duty on the state to have due regard for animal welfare - as captured in Article 13 of the EU Lisbon Treaty - must be enshrined in UK law. This Bill captures the substantive obligation that Article 13 currently puts on the national government to consider animal welfare, as well as explicitly recognising animals as sentient beings."
"Today’s draft Bill lays out in black and white the Government making good on its promises, to ensure the UK remains a global leader in animal welfare post-Brexit."
40% of the dry food is a 'flour' made from Hermetia illucens larvae reared in a new, £18 million facility in Holland. Other ingredients include British grown oats, potato and a number of other botanicals.
Insects require only a small fraction of the resources to farm than other forms of protein, such as chicken or beef. The manufacturer says that compared to beef, its grubs need just 2% of the land and 4% of the water to produce each kilogram of protein, which means they generate 96% less greenhouse emissions. And they don't need any antibiotics or growth hormones.
The manufacturer also says insects are easier to digest than chicken, making Yora ideal for pets with sensitive stomachs.
TV vet Rory Cowlam MRCVS is throwing his weight behind the new dog food. He said: "Yora provides a healthy, high protein alternative to conventional kibble. It’s hypoallergenic, and free from antibiotics and growth hormones. Pets love the taste – plus it’s great for the planet.
"As a keen conservationist and dog lover, I am incredibly excited by the enormous potential for this dog food to reduce our pets’ collective carbon pawprint."
Tom Neish, founder of Yora, said: "Animals and humans have been eating insects since the dawn of time and we believe Yora is the future of pet food. We have trialled 29 recipes to find the perfect combination of great tasting ingredients and are very proud of the end result.
"Yora enables dog owners to take the lead in giving their dog a nutritious, tasty food whilst having a positive impact on the environment."
Yora is available to buy online or from Pets Corner stores, priced at £13.99 for a 1.5kg bag.
If you're interested in stocking Yora at your practice, contact Hollie Smith, Marketing and Operations Manager on 01293 265618, or email hollie@yorapetfoods.com
Now, I'm off to buy a bag for my dog. I figure it should be easier to persuade Daisy that an insect-based diet is necessary to save the planet, than my wife.
The charity, which was set up over 120 years ago, says the number of calls and emails it gets from industry professionals seeking help has increased 500% over the last 5 years; it has received more than 1,500 calls and emails over the past 12 months.
Lynne Hill, Chief Executive of Linnaeus said: "The veterinary industry is fast-paced and, at times, an extremely stressful environment, so the support on offer from Vetlife is particularly valuable and its worth is demonstrated by the significant increase in contact being made to it.
"We hope this donation will help Vetlife continue to provide the excellent service and support they have given to vets and nurses for so long."
Vetlife President Geoff Little said: "This donation from the Linnaeus Group is extremely generous. We have seen a dramatic rise in calls and emails to the service over recent years. So much so, we have recruited additional volunteers to cope with the additional contacts. It’s extremely gratifying to see the number of volunteers who are so willing to put something back into their profession and to help others.
"At Vetlife, we provide support in the shape of three core services, which are the Vetlife Helpline, which provides independent, confidential support 24/7, 365 days a year; Health Support, run by mental health professionals; and Financial Support, which provides assistance to vets or their dependents who find themselves in difficulty.
"This support from Linnaeus will help us to bridge the gap as the need for support continues to grow."
Anyone who needs support can contact the Vetlife Helpline on 0303 040 2551 or anonymously via www.vetlife.org.uk.
Photo: Vetlife President Geoff Little receives the £60,000 donation from Lynn Hill at Linnaeus.
Virbac has launched a new 12 month version of Suprelorin, the reversible medical castration implant for dogs, widening the options for clients seeking an alternative to surgical castration.
Product manager Chris Geddes MRCVS said: "The launch of Suprelorin 12 gives practices the chance to offer dog owners a more convenient castration option. The implant renewal can now be included with their dog's annual boosters or health check.
"The slow-release implant is inserted at the back of the neck in the same manner as a microchip. There is no anaesthetic, no surgery and no scarring. The current implant, which contains 4.7mg active and lasts for around 6 months after insertion, will continue to be available for those wanting a more brief solution or as a trial.
"Deslorelin is a GnRH superagonist which causes suppression of LH/FSH, and therefore testosterone production, leading to temporary infertility."
For further information on Suprelorin/12, please call and ask to speak to one of our veterinary advisors on 01359 243243, or contact your local Virbac territory manager.
Nine-year-old Nigel the puma, from Lincolnshire Wildlife Park, was suffering from a deteriorating arthritic condition, which was causing loss of function in his front leg.
His veterinary team consulted an orthopaedic specialist and trialled medical management including steroids and Solensia, but Nigel was unresponsive to treatment.
This led to a severe debilitating limp and pain, leaving a choice between amputation or euthanasia.
Nigel's treatment was funded by donations from visitors to Lincolnshire Wildlife Park, which is a registered charity that was originally established as a sanctuary for parrots in the early 1990s, who raised nearly £5,000 following a fundraising campaign.
The operation took place in a sterile theatre set up in Nigel’s enclosure, where the entire limb was removed, including the scapula.
After an intense five-hour operation, led by Iain Cope, veterinary surgeon and practice owner at Vets4Pets Newmarket, and Shannon Grimwood, veterinary nurse at Vets4Pets Newmarket, Nigel is now on the road to recovery and adapting well to life with three legs.
Iain said: “Nigel’s case was certainly unique and one we haven’t come across before. Working alongside Lincolnshire Wildlife Park and a team of local vets and veterinary nurses, we applied our knowledge of domestic cat amputations to a big one.
“The approach was extremely similar, and the operation ran as smoothly as possible.”
400 people took part in the research, of which 76% described their mental health as ‘reasonable’ or ‘very good’, while almost three quarters 71% said there was someone at work they could talk to about their mental health and 80% knew where to access information and support.
This compared to 2019, when only 50% had even recognised veterinary wellbeing as an issue.
So far so good.
However, on the flip side, 60% felt that their work/life balance was not right and 82% were worried about their financial situation.
As is well known, the pandemic placed further strain on veterinary professionals: 78% of respondents said their workload had increased since it struck, and 44% said they were working longer hours.
What's more, 63% felt that that changes in working practices introduced during the pandemic had not been beneficial to their mental health.
The survey results showed a number of interesting variations depending on the respondent's time in the profession and their role.
For example, people who've been in the profession for more than ten years appeared to be more resilient than those who've been in the profession for six years or less, with 66% of the older hands saying the pandemic had had an impact on their mental heath, compared to 71% of the younger respondents.
The older crowd also reported being more aware of where to access support and information (89% vs 71%) but feel they have fewer people they can talk to at work (68% vs 76%).
Interestingly, nurses felt they had more people they can talk to at work (76% vs 62% of vets)
The organisers say that overall, the research suggests that the veterinary profession is more aware of the pressures on veterinary teams and is taking some steps to mitigate it and support staff better.
97% said they felt supported by their colleagues, 75% said they felt that their practice had strong leaders and managers and 90% said that they loved their job.
50% said their practice offers online resources to support wellbeing at work, 41% offer counselling and 40% offer flexible working.
When asked what more could be done to improve their wellbeing at work, simple solutions such as taking a lunch break, having a pleasant room at work in which they could relax and receiving recognition for hard work were the most commonly proposed.
VET Festival will be offering a Wellness Hub, supported by MWI Animal Health, in which a range of practical activities will be offered to support delegates in improving their day-to-day wellbeing, with representatives of Vetlife also on hand to offer advice and support.
Tickets for VET Festival can be bought here: https://www.vetfestival.co.uk/delegate-info/ticket-information
Vetoquinol is launching Forcyl, an injectable anti-infective for the targeted therapeutic treatment of respiratory infections in cattle, in November.
Forcyl is a patented 16% marbofloxacin solution, registered as a single intramuscular injection, which the company says will ensure a high level of compliance.
Forcyl follows the SISAAB concept (single injection short acting antibiotic), with an optimised dosage to minimise the risk of development of antibiotic resistance. Shorter exposure time limits the opportunity for resistance to develop. The formulation means a lower volume of administration (10 ml for 160 kg body weight) is required. Vetoquinol says that other benefits of Forcyl include excellent injection site tolerance and short withdrawal periods (meat: 5 days, milk: 48 hours).
For further information on implementing the SISAAB concept in your practice, please contact one of Vetoquinol's large animal team on 01280 814500.
Andrew Harrison, a partner at Three Counties Equine Hospital in Gloucestershire, has been appointed as the new President of the British Equine Veterinary Association (BEVA) for 2014/15.
Andrew took over the role from Paul Jepson at the end of BEVA Congress last week. Mark Bowen, Associate Professor of Veterinary Internal Medicine at The University of Nottingham School of Veterinary Medicine and Science, becomes President Elect.Andrew said: "It is a privilege and an honour to take up the presidential reins for the next 12 months. It is unrealistic to expect to "change the world" in such a short time frame so the plan is to target certain areas, such as progressing New Safer Horse Rescue courses, strengthening BEVA's relationship with the BHA and moving forward with the regulation of Musculoskeletal Paraprofessionals. Not least it is a priority this year to make sure we keep aspiring vets realistically informed about future employment in our profession given the proliferation of undergraduate places available at UK and English speaking mainland European vet schools."
For further information visit www.beva.org.uk.
Musculoskeletal therapists currently have their work underpinned by an Exemption Order to the Veterinary Surgeons Act 1966 which allows them to treat an animal under the direction of a veterinary surgeon who has first examined that animal.
The College says it has recognised that there has been confusion over whether musculoskeletal therapists need a veterinary referral for maintenance work, such as massage, in a healthy animal. This may lead to delays in animals receiving maintenance care.
The new guidance, found in Chapter 19 (www.rcvs.org.uk/unqualified) of the supporting guidance to the Code of Professional Conduct, sets out the existing rules for musculoskeletal treatment of illness, disease or pathology, and clarifies that healthy animals do not need a veterinary referral for maintenance care.
The guidance stresses that musculoskeletal therapists are part of the vet-led team, and that any animal, including healthy ones, should be registered with a veterinary surgeon and referred to a vet at the first sign of any symptoms that may suggest underlying health issues.
The guidance also says that vets should be confident that the musculoskeletal therapist is appropriately qualified; indicators of this can include membership of a voluntary regulatory body with a register of practitioners, and associated standards of education and conduct, supported by a complaints and disciplinary process.
In March 2019 the RCVS published the Review of Minor Procedures Regime (www.rcvs.org.uk/document-library/report-to-defra-on-the-review-of-minor-procedures-regime-and/) which noted that the existing exemption order was not suitable for underpinning the work of musculoskeletal therapists, and recommended that this be remedied by reform of Schedule 3 of the Veterinary Surgeons Act, alongside regulation by the RCVS through Associate status for musculoskeletal therapists.
This would allow the RCVS to set and uphold standards for musculoskeletal therapists in a similar way to veterinary nurses, giving further assurance to both the veterinary professions and the public. The recent Legislation Working Party Report recommendations builds on that recommendation, and is currently open for consultation at www.rcvs.org.uk/consultations
Themed 'Controlling Disease Threats at Home and from Abroad’, this year's conference will highlight the increasing importance of OVs in safeguarding the UK’s international trade and in protecting human health through disease surveillance and control.
The conference programme includes dedicated lecture streams aimed at large animal, small animal and equine practitioners. Improve says that lecture content has been tailored to cover areas of key relevance for more than 8,000 OVs due to revalidate their qualifications in March 2019. The programme also includes interactive workshops, including drop-in question and answer sessions offering practical advice and guidance on the revalidation process.
An exhibition of products and services for OVs runs alongside the conference.
David Babington MRCVS, Business Development Director at Improve, said: "This conference remains the only event dedicated to the needs of OVs. They receive industry updates from leading figures in the veterinary sector, attend lectures on OV work from experts and, in so doing, work towards their CPD revalidation requirements. We’re currently finalising a packed programme for this year’s conference and urge OVs to take advantage of our time-limited Early Bird offers and register without delay."
For more information on the Official Veterinarian Conference and Exhibition or to register visit: www.officialvet.com
Boehringer Ingelheim Vetmedica has extended its Metacam 0.5 mg/ml Oral Suspension for Cats range with the launch of a 30ml bottle size, which the company says will last the average 5 kg cat for two months.
According to Boehringer, the new 30ml bottle will offer owners a cost saving compared to purchasing two 15 ml bottles. In addition, it will provide greater prescription options for veterinary practices currently stocking 3ml and 15 ml bottles,,
Andrew Francis, Metacam brand manager said: "The new 30ml bottle of Metacam Oral Suspension for Cats will provide both veterinary practices and their clients with a product that is great for the long-term treatment of chronic pain in cats in one convenient pack."
For further information on Metacam, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
A new solution to a problem vets encounter when using a conventional, usually human health, laryngoscope on small animals has been devised by Prof Paul Flecknell of Newcastle University in collaboration with Alstoe Animal Health.
Called the FlecknellTM , this small animal laryngoscope uses a specially-designed, streamline, slimmed-down blade to maximise the view of the larynx, particularly with rabbits in mind. According to Alstoe, the new design also greatly reduces the risk of damage to an animal's gums or pharynx as the blade is inserted.
Prof Flecknell, MA, VetMB, PhD, DECLAM, DLAS, DECVA, (Hon) DACLAM, (Hon) FRCVS said: "Many practitioners have complained that existing blades were not suitable for small animal work and they were not happy with using a blind technique, as they really wanted to see the larynx and intubate under direct vision.
"So, over several years of development, we worked through prototypes and changed both the shape of the blade and the type and position of the light source. As well as trying the prototypes ourselves, Alstoe carried out trial work with vets in practice, resulting in this final design, which we think is much easier to use than other blades currently on the market.
"We hope this will encourage vets to intubate more rabbits, since this will enable them to be anaesthetised more safely. One of the commonest problems seen is depressed respiration progressing to apnoea, and trying to assist ventilation using a face mask often results only in inflation of the stomach, making matters worse. Once an endotracheal tube is in place, ventilation can be assisted easily if needed."
Niall McFerran from Alstoe said: "The Flecknell still requires some practice to master the use of the blade, and so we have produced a DVD and leaflet demonstrating its use. The Flecknell blade can be used to intubate a range of small animals, cats, dogs, as well as the original target rabbits.
"We were delighted to have worked with such an eminent specialist as Prof Flecknell and his team on a genuinely vet-led need to help with animal welfare. And this is just the start, as 2009 is going to be the busiest ever year for new product introductions for Alstoe Animal Health."
For more information, contact Alstoe Animal Health www.alstoe.co.uk
Charlie says that uniquely, the company offers feedback about samples submitted, with the aim of teaching veterinary staff the skills needed to interpret future samples themselves.
Cytovet is aimed at nurses and new grads who want to improve their cytology skills, vets who don’t have time to look at their own samples or have a tricky case they would like an additional opinion on, and those vets whose clients can’t afford the prices the big labs quote.
Charlie said: "I’m a vet with 16 years of clinical experience and a certAVP which focussed on small animal medicine and clinical pathology.
"I currently work in first opinion charity practice and have examined thousands of cytology samples over the years.
"I have been writing cytology reports for the practices I have worked for since 2012.
"I believe all vets and nurses should have the basic microscope skills required to help make more informed decisions for their patients, particularly in a world of escalating veterinary costs and antimicrobial resistance.
"I can examine both digital images and posted slides using a top-of-the-range trinocular digital microscope.
"All you need to do is submit the patient information and slides to me (digital images or actual slides) via my website and I will provide you with a report within 3-5 days."
Urgent turnaround is also available.
www.cytovet.co.uk
The webinar, which takes place on Thursday 30th June at 7.30pm, is being presented by Debbie Boone, billed as one of America’s most prominent and experienced veterinary communications consultants.
Gerrard Harkins, Premier Vet Alliance’s Commercial Director said: “Many people struggle with managing challenging behaviour and confrontation in the workplace and Debbie will be focusing on providing delegates with pragmatic advice and skills to put into practice.
"She is one of the veterinary industry’s most prominent and successful communicators so we’re extremely fortunate to be able to access her advice.
“We’re also looking forward to gaining a US perspective on this important subject.”
To register for the webinar, visit: https://tinyl.io/5aIk
Ian graduated from the University of Liverpool and gained his PhD from the University of Glasgow. He gained both the UK and European Diplomas in Small Animal Medicine at the University of Cambridge and is a Royal College of Veterinary Surgeons and European Recognised Specialist in Small Animal Medicine. He returned to Glasgow University in 1998 and has been the Professor of Small Animal Medicine since 2009.
Ian has published in the fields of infectious diseases, endocrinology and neurology but is interested in all aspects of small animal medicine. In 2015 he was awarded the BSAVA Woodrow Award for his contribution to small animal medicine. In 2016 he became of Fellow of the RCVS, thereby becoming a jolly good fellow Fellow of the RCVS, or JGFFRCVS for short.
Professor Ramsey has served BSAVA as a regional secretary, member of several committees and chair of Petsavers and Scientific. He is probably best known as the editor of four editions of the BSAVA Small Animal Formulary.
The Presidential handover usually takes place at BSAVA Congress but was delayed this year given the cancellation of the April event due to coronavirus.
Ian says that during his Presidency, he intends to promote and enhance the digital offering of the Association to BSAVA members coping with the pandemic. He will also oversee changes to BSAVA congress with a more interactive approach to training; shortened, more focussed lectures and greater integration between the exhibition, the scientific content, and the social events.
Ian said: “At this time of great uncertainty in the profession, my focus will be on providing BSAVA members with the scientific information and clinical training that they need, in a suitable form. Clinical skills and science lie at the heart of being a good vet and BSAVA members get access to a huge range of cheap or free resources in these areas to help them in their careers. Congress 2021 will be evolving as a vital part of this effort and I am looking forward to welcoming everyone to Manchester during the last week of March 2021."
MSD Animal Health has launched Bovilis IBR Marker Inac, an inactivated marker vaccine for use in the control of Infectious Bovine Rhinotracheitis (IBR).
The company says the new product complements Bovilis IBR Marker Live and creates a range now offering greater simplicity and additional flexibility for veterinary surgeons seeking optimum control protocols for their clients' herds.
MSD Animal Health ruminant veterinary adviser Drew McGurren MRCVS said: "Farmer compliance is an important part of any successful vaccination programme. With this extended Bovilis IBR Marker programme, farmers can now start IBR vaccination of their cattle from three months of age with a single shot primary course of Bovilis IBR Marker Live, easily followed by boosters every six months using a single dose of either Bovilis IBR Marker Live or Bovilis IBR Marker Inac. Both primary course and boosters can be administered by the same intramuscular route.
"Alternatively, Bovilis IBR Marker Inac can be administered to cattle from three months of age as a primary course of two injections four weeks apart. The programme then follows a six monthly single dose booster regime.
"The availability of Bovilis IBR Marker Inac provides a simple control option in defined farm situations, not least where an alternative to the live vaccine is preferred or required. Overall, we see this development adding convenience, ease of use and flexibility for veterinary surgeons as they work with their clients to control a significant disease threat in dairy and beef cattle in the UK."
Bovilis IBR Marker Inac is a prescription-only medicine (POM-V). The product is available from wholesalers now in 10 and 50 dose vials. For further information, contact the MSD Animal Health Veterinary Support Group on 01908 685685.
For the study, the researchers analysed rehoming adverts placed on the websites of 16 Dogs Trust and RSPCA centres in 2015 and 2018. Data was collected on 1793 dogs across the 16 centres.
The percentage of dogs classified as 'extreme brachycephalic' using the Kennel Club definition increased from 2.76% (n=24) in 2015 to 5.19% (n=48) in 2018.The researchers speculate that owners may be passing on the financial burden of caring for and treating chronic health issues in brachycephalic dogs to the rehoming charities.
Dr Anne Carter, Senior Lecturer in Animal Science at Nottingham Trent University said: "The increasing numbers and rising popularity of brachycephalic breeds is already influencing the demographic spread in rescue centres. This pattern that is likely to continue, particularly as these dogs reach 3–4 years old, which we have found is the most common age for dogs being relinquished.
"Differing breeds require highly contrasting intensities of care, housing, and particularly veterinary care. Owners may often choose brachycephalic dogs with limited consideration for their potential health conditions. These dogs then enter rescue centres, placing additional strain on resources due to cost of treatment and additional length of stay for recovery.”
Reference
The RCVS Disciplinary Committee has removed a veterinary surgeon formerly working in Lincolnshire from the Register, after finding him guilty of serious professional misconduct for drink-driving related convictions, failing to inform his employer of these convictions, and driving whilst disqualified.
Jaroslaw Slominski, a former employer of Grants Veterinary Services plc, chose not to attend the three-day hearing. The Committee considered whether to proceed with the case, using criteria identified by the Court of Appeal in R v Jones (Anthony) in 2002 and confirmed by the House of Lords. It concluded it was in the interests of justice that the hearing should go ahead.
The charges related to two convictions Mr Slominski received on 17 March 2010 at Lincoln Magistrates Court: failure to provide a specimen of breath for analysis and driving without due care and attention (after his vehicle collided head-on with another car). Mr Slominski failed to inform his employers of these convictions, as he was contractually obliged to do, and that he was now disqualified from driving.
Having heard evidence from Mr Slominski's line manager, the Committee also found that he had driven his employer's vehicle whilst disqualified, although it could not be sure that he had done so on all the occasions alleged. Therefore, the Committee did not go on to consider an alternative part of the charge - that Mr Slominski had dishonestly claimed money from his employer by falsely submitting expenses claims.
Disciplinary Committee Chairman Prof Peter Lees said: "The combination of factors in this case, namely, the serious nature of his conviction in failing to provide a specimen of breath, his subsequent premeditated conduct in not informing his employers and driving whilst disqualified should be treated by the profession very seriously. The Committee has concluded that the combination of the conviction and the conduct is incompatible with Mr Slominski practising as a veterinary surgeon."
The Committee directed that Mr Slominski's name be removed from the Register.
It has long been known that diabetes is a disease that requires an individualized treatment protocol in order to manage the condition. The Insuvet range includes Insuvet Lente with medium duration and onset, Insuvet Protamine Zinc with longer duration and onset (an ideal choice for some cat owners who may find twice daily injections problematic), and Insuvet Neutral, which should be kept in every practice to manage acute diabetic ketoacidosis.
Susan Mitchell, Insuvet Product Manager said: "A flexible approach allows patients to be managed more effectively; both from the point of view of the patient's needs but also those of the owner too. People have increasingly busy schedules and providing a solution that fits with lifestyle and helps deal with any diabetic crises that do occasionally occur, will ensure successful long term management of the condition."
The team at Pfizer has been busy undergoing intensive technical training and is equipped to provide assistance with diabetic cases. Regional support is now available in the shape of dedicated Area Veterinary Managers who can provide practices with comprehensive support, backed up with a national technical support helpline.
The company has available a wide range of support materials that include stabilisation protocols, blood glucose monitoring charts and communication aids that explain the condition to the client, with the promise of an even more comprehensive range of exciting and innovative aids to come in the next few months.
For further information on the Insuvet range vets and nurses should contact their Pfizer Business Account Manager. For advice on individual cases or any other technical questions about diabetes call the Technical Support Line on 0845 3008034.
The new aids will make their debut at this month's Vet Festival (20-21 May 2022, Loseley Park, Surrey).
The Flexi-Wedge (pictured) positioning aid aims to deliver both better quality and easier to interpret imaging, and to facilitate the ideal positioning of surgical patients.
The second product is the Saddle-Sandbags, which The Big Dog Bed Company says address two problems – the need to hold a patient in place without loading weight to any part of the body and the tendency of existing sandbags to leak sand after a few months of manipulation to different shapes.
Dru Ross, Director at Big Dog Bed Company said: “Support wedges are obviously widely used in the veterinary field.
"The difference with the design of the Flexi-Wedge is that they can be held securely in the desired position and are fully adjustable, making them suitable for a wide range of patient size and shape”.
“The Saddle-Sandbag is designed for those situations when a limb needs to be held out securely without any load on it and standard sandbags are not suited to this purpose.
"There is no need to manipulate the sandbag to the desired shape.
"The weight is split between two bags joined by a broad central strap so the strap is placed round or over the limb”.
James Weston, Managing Director at Northwest Referrals was one of the first to use the Flexi-Wedge.
James said: “I’ve never had such a straight spine when scanning a greyhound before using these supports. Every CT scanner should be sold with these”.
Patrick Harte MRCVS from the The Sidings Veterinary Surgery said: “The weighted ends make these sandbags much easier to handle.
"The larger aid is excellent for holding upper thoracic limb out of the way for lateral views of the elbow, for instance and the width of the flat part of the aid is perfect for wrapping around the antebrachium of the thoracic limb.”
The Flexi-Wedges and the Saddle-Sandbag products use waterproof, antibacterial, wipe clean fabrics in which the seams are thermally welded so no moisture can enter and no sand can escape.
The Flexi-Wedges are available in two lengths 60cm and 90 cm.
They are supplied with wipe clean straps that can be tailored to the size of table on which they are used.
The Saddle-Sandbags are available in three sizes.
Ceva Animal Health has renamed Tildren, its tiludronate-based bisphosphonate infusion for the treatment of bone spavin in horses, as Equidronate.
Tiludronate has been used to treat bone spavin and navicular disease in Europe for many years and was licensed for bone spavin in the UK in 2008. Ceva says trials published last year show that horses suffering lameness caused by bone spavin can show marked improvement following treatment with an Equidronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints and is considered to be one of the most common forms of hindlimb lameness in the horse. Horses with bone spavin experience abnormal bone remodeling changes. According to the company, Equidronate helps to modulate the osteoclasts to help prevent excessive bone removal and give the osteoblasts a chance to catch up. This in combination with adjusting levels of exercise helps to harmonise the bone adaptation needed for the horse to perform its athletic duties.
In the trials one in four horses showed marked improvement; two in four showed improvement, which, when combined with other treatment, enabled the horse to resume former levels of activity and one in four horses showed no response.
Ceva Animal Health has produced a range of explanatory leaflets for horse owners on bone spavin, navicular disease and sacroiliac disease, as well as a helpful booklet detailing the discharge procedures for horses that have been treated with Equidronate.
For free copies and for further product information contact your Ceva sales representative, ring Ceva on 01494 781510 or visit the website at http://www.ceva.uk.com/
Virbac has announced the launch of Carprox Vet, a carprofen-based NSAID indicated for the alleviation of post-operative pain and inflammation following orthopaedic and soft tissue surgery in dogs and cats and for the treatment of chronic pain and inflammation in dogs.
Carprox is presented as a palatable tablet for dogs in three sizes - 20 mg, 50 mg and 100 mg. An injectable 50 mg/ml solution for dogs and cats has also been launched (in bottles of 20ml).
Virbac Marketing Manager for Companion Animals Simon Boulton MRCVS said: "We launched our meloxicam-based solution for acute and chronic pain, Inflacam, in 2013. With the arrival of Carprox Vet, we are now able to offer vets a carprofen-based alternative for added flexibility and choice. We are delighted to add it to our product range and are proud to say that Virbac now offers one of the widest ranges of products for the treatment of small animals in the UK."
MsRCVS Sean Cleary and Richard Thomas, and accountant Jane Platt have opened their first practice, Burford Lane Vets in Cheshire, and now plan to open 10 more practices over the next five years, two in Spring 2022
Burford Lane Vets is headed up by Pieter De Villiers MRCVS, who has become an equity owner, supported by a team of nine vets, nurses and receptionists.
Sean said: “Our vets benefit from our many years of clinical, financial, human resources and procurement experience and have the opportunity to add the finishing touches to a state-of-the-art practice, where no expense has been spared on the fit out and equipment.
"Everything from finding a property, negotiating the lease, fitting out the practice and health and safety is taken care of.
"It means our equity partners can enjoy being fantastic vets and reap the financial rewards that brings, and we are here to support the practice and take care of all the administration, procurement, marketing and everything else that goes into running a successful business."
Sean added: “We have benefited from the shift in the industry that saw veterinary groups acquired by large corporate businesses.
"However, this has inadvertently made it difficult for the next generation of vets to follow the traditional route of buying into a practice as they progress from a junior role to partner, as corporate interest has pushed the values of practices to unaffordable levels for most vets.
"We want to bridge that gap and give a leg up to vets who want to be masters of their own destinies, without the difficulty of starting from scratch or having to find a huge initial investment.”
Sean says he thinks there are a great many vets who would like to launch their own practice.
However, starting from scratch is fraught with risk, expense, and complexity.
Sean added: “Our innovative model helps great vets set up in business as leaders of their own practice and our unique offering is already attracting interest from high-calibre individuals.
"We would encourage any colleagues out there who feel they would like to join us in our new venture to get in touch via our website.”
Sean concluded: “The business acumen we have built up over our many years of working in the industry enables us to provide practical support, mentorship and guidance for vets through every step of the process, and that’s something we’re passionate about.
"The directors will be working across all practices to provide support whenever it’s needed. We are in it for the long haul, not just the initial set up stage, and we will become a part of every practice that opens.
“We take a real pride in being the solution to fix the broken practice ownership model and North Star Vets will empower ambitious vets to enjoy a better and more successful future, which in turn will translate into the standard of care our clients enjoy.”
The current strain of bluetongue emerged in the Netherlands in 2023 and spread rapidly, infecting over 5,000 livestock farms.
Infection of livestock with this serotype of the virus can result in severe clinical signs and high mortality rates1, significantly impacting animal health, and farming communities.
Bultavo 3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3.
Boehringer says that in sheep, Bultavo 3 has been shown to significantly reduce viraemia and prevent mortality and clinical signs associated with BTV-3 infection.
Onset of immunity occurs three weeks after administration of a single 1ml subcutaneous dose in sheep.
In cattle, two 1ml intramuscular doses are required, at a three-week interval.
Findlay MacBean, Head of Livestock, UK and Ireland at Boehringer Ingelheim, said: “It’s great news that we can support farmers and authorities in their fight against bluetongue with our new BTV-3 vaccine, Bultavo 3.
"As we have seen across Europe, and now in the UK, BTV can spread rapidly and causes considerable stress to farmers because of the significant financial impact on those affected.
The availability of Bultavo 3 means future BTV-3 outbreaks can be suppressed, helping farmers protect not only their herds, but also their livelihoods.” Oli Maxwell, BVSc BSc(Hons) MVM DipECBHM, RCVS Recognised Specialist in Cattle Health and Production and Clinical Director of Green Counties Vets said: “Farmers are justifiably concerned about BTV-3 and its incursion into the UK again this year.
"Reports from colleagues on the continent regarding the severity of clinical signs, especially in sheep are worrying.
"We have seen a huge increase in clients asking about the disease, progress on a vaccine and what this may mean for animal movements at a critical time of year.
"The availability of a safe and effective vaccine as a critical tool against a disease that we can’t reasonably prevent with biosecurity measures will be a welcome development for many.”
To manage supply and demand, use of the product will initially be subject to geographical restriction with vaccination permitted in high-risk English counties: Norfolk, Suffolk, Essex, Kent and East Sussex.
Reference:
Assets coming up for sale via private treaty and online auction include:
For a full list of assets, visit: https://www.bidspotter.co.uk/en-gb/auction-catalogues/timed/gordonbrothers/catalogue-id-gordon10067
Gordon Brothers Valuations & Industrial Director, Simon Bamford said: “Gordon Brothers is pleased to be assisting the Trustees of the Animal Health Trust with the orderly closure of the 100 acre Newmarket facilities, including the sale of the large quantity of associated assets. We are expecting significant interest in the varied array of assets”
The online auction will close at 3.00pm on the 1st October 2020. Viewing is strictly by appointment only on Monday 28th and Tuesday 29th September 2020 from 9.00am to 4.00pm at AHT, Lanwades Park, Kentford, Newmarket, CB8 7UU.
For further enquires on the sale or to view by appointment please contact, Josh Chivers jchivers@gordonbrothers.com
A second sale comprising of a large quantity of laboratory and research equipment and agricultural plant and machinery will take place in October 2020 with further details to be released.